IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Est. Return 65.21%
This Quarter Est. Return
1 Year Est. Return
+65.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$672M
AUM Growth
+$124M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
266
New
Increased
Reduced
Closed

Top Buys

1
+$23.4M
2
+$15.9M
3
+$15.5M
4
XFOR icon
X4 Pharmaceuticals
XFOR
+$15.4M
5
RLMD icon
Relmada Therapeutics
RLMD
+$10.2M

Top Sells

1
+$29.5M
2
+$19.7M
3
+$18.8M
4
BMY icon
Bristol-Myers Squibb
BMY
+$17.9M
5
CLDX icon
Celldex Therapeutics
CLDX
+$15.8M

Sector Composition

1 Healthcare 98.54%
2 Consumer Staples 0.23%
3 Financials 0.12%
4 Industrials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$23.4M 0.79%
+125,000
2
$22.5M 0.76%
87,166
+59,619
3
$22.4M 0.75%
135,842
4
$15.9M 0.54%
+500,469
5
$15.5M 0.52%
+200,000
6
$15.4M 0.52%
1,597,514
+365,001
7
$13.8M 0.47%
61,018
-17,732
8
$12.3M 0.41%
596,290
-768,700
9
$12.1M 0.41%
15,515
+7,917
10
$12.1M 0.41%
250,000
+100,000
11
$11.5M 0.39%
640,576
+417,403
12
$11.2M 0.38%
330,989
+50,000
13
$11M 0.37%
437,430
-749,270
14
$10.6M 0.36%
1,836,545
15
$10.2M 0.34%
649,542
16
$10.2M 0.34%
+290,207
17
$9.9M 0.33%
501,110
+225,000
18
$9.7M 0.33%
1,048,383
19
$9.27M 0.31%
+22,813
20
$9.05M 0.3%
15,615
-692
21
$8.7M 0.29%
1,308,699
-157,448
22
$8.47M 0.29%
21,934
-5,000
23
$8.32M 0.28%
225,926
+202,278
24
$8M 0.27%
62,090
-25,000
25
$7.69M 0.26%
+264,868
1
2 3 4 5